Yap ablation inhibits AKT/c-Met/SNAI1-induced liver tumor formation.
A, Study design. B, Survival curve.
C, Liver weight and liver/body ratio of
Yapflox/flox mice injected
with AKT/c-Met/pT3 or AKT/c-Met/SNAI1. D, Representative gross and
hematoxylin and eosin (H&E), CK19, and Ki-67 staining images of livers from
Yapflox/flox mice injected with
AKT/c-Met/SNAI1/pCMV or AKT/c-Met/SNAI1/Cre plasmids. Scale bar, 100 μm.
***, P < 0.01; ****, P < 0.0001.
W.p.i., weeks post injection.